Author

T. A. Bates

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 6 Research Focus:host-pathogen & immune response· 5 Organism:human· 4 Assay:proteomics· 4 Organism:Arabidopsis· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:metabolomics· 1

Frequent Co-Authors

F. G. Tafesse· 4 shared E. Barklis· 2 shared H. C. Leier· 2 shared J. B. Weinstein· 2 shared M. Trank-Greene· 2 shared S. E. Farley· 2 shared S. K. McBride· 2 shared A. Anastas· 1 shared

Activity by Year

2020-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

F. G. Tafesse

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

ESAT-6 undergoes self-association at phagosomal pH and an ESAT-6 specific nanobody restricts M. tuberculosis growth in macrophages

T. A. Bates, M. Trank-Greene, X. Nguyenla, A. Anastas, S. Gurmessa, I. R. Merutka, S. D. Dixon, A. Shumate, A. R. Groncki, M. A. Parson, J. R. Ingram, E. Barklis, J. E. Burke, U. Shinde, H. L. Ploegh, F. G. Tafesse

This study investigates ESAT-6's self-association under acidic conditions and shows an ESAT-6-specific nanobody inhibits M. tuberculosis growth in macrophages.

bioRxiv · Aug 16, 2023Biochemistry

Diverging maternal and infant cord antibody functions from SARS-CoV-2 infection and vaccination in pregnancy

E. H. Adhikari, P. Lu, Y. J. Kang, A. R. McDonald, J. E. Pruszynski, T. A. Bates, S. K. McBride, M. Trank-Greene, F. G. Tafesse, L. L. Lu

This study compares maternal and infant cord antibody responses to SARS-CoV-2 infection and vaccination during pregnancy, finding differences in neutralizing activity, Fc effector functions, and glycosylation patterns.

bioRxiv · May 1, 2023Immunology

The E2 glycoprotein holds key residues for Mayaro virus adaptation to the urban Aedes aegypti mosquito

F. Roesch, C. Cereghino, L. Carrau, A. Hardy, H. Ribeiro-Filho, A. Henrion Lacritick, C. Koh, J. Marano, T. A. Bates, P. Rai, C. Chuong, S. Akter, T. Vallet, H. Blanc, T. Elliot, , J. Weger-Lucarelli

This paper identifies a mutation in the E2 glycoprotein of Mayaro virus that enhances transmission in Aedes aegypti but reduces replication in human cells, suggesting a trade-off in host adaptation.

bioRxiv · Apr 5, 2022 · PreprintMicrobiology

A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants

S. E. Farley, J. Kyle, H. Leier, L. M. Bramer, J. Weinstein, T. A. Bates, J.-Y. Lee, T. O. Metz, C. Schultz, F. Tafesse

The paper identifies glycerolipid biosynthesis as a conserved host dependency factor for SARS-CoV-2 by mapping lipid metabolism changes across variants.

bioRxiv · Feb 14, 2022Microbiology

A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants

J. B. Weinstein, T. A. Bates, H. C. Leier, S. K. McBride, E. Barklis, F. G. Tafesse

This paper describes a potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants with high efficacy and stability.

bioRxiv · Jan 18, 2022Immunology

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2

T. A. Bates, J. B. Weinstein, S. E. Farley, H. C. Leier, W. B. Messer, F. G. Tafesse

This study evaluates cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2 and finds a high proportion of tested antibodies show cross-reactivity, suggesting potential utility in research and therapeutic development.

bioRxiv · Jul 30, 2020Immunology